FDA Approves New Painkiller with Reduced Addiction Risk
The US Food and Drug Administration has given its approval to a new type of painkiller called Suzetrigine, sold as Journavx. This medication is administered twice daily in 50-milligram oral tablets to treat moderate and severe acute pain. Clinical trials have shown that Suzetrigine can effectively manage pain, rivaling the effects of opioid-based medications. The … Read more